Top Stories

• 

  DOL Rule Would Expand Alternatives In Retirement Plans

  By Kellie Mejdrich

  The U.S. Department of Labor unveiled a proposal Monday to expand access to alternative investments, like privat...(read more)

• 

  BofA Will Pay $72.5M In Deal Ending Epstein Ties Allegations

  By Hailey Konnath

  Bank of America agreed to pay $72.5 million to put to rest a proposed class action alleging the bank helped faci...(read more)

• Calif. Judge Puts Nexstar-Tegna Merger On Ice During Review

  By Christopher Cole

  A California federal judge has blocked broadcast giants Nexstar and Tegna from combining operations in their $6.2 billion merger while a legal challenge from DirecTV moves forward, saying the satellite TV company showed irreparable harm could occur from the deal.

• 5th Circ. Calls Pharmacy GLP-1 Args 'Tough Pills To Swallow'

  By Spencer Brewer

  A Fifth Circuit panel pushed multiple compounding pharmacies to explain why they should get to compound lucrative drugs used for weight loss, including Ozempic, saying Monday that its options if it sides with the pharmacies are "tough pills to swallow."

• Justices Doubt Gov't Venue Theory In Twitter Employee Case

  By Marco Poggio

  The U.S. Supreme Court on Monday appeared sharply skeptical that a former Twitter employee convicted of emailing a falsified document to FBI agents from his Seattle home could be prosecuted in San Francisco, with several justices questioning the federal government's justification for bringing the case where none of the charged conduct occurred.

• Colo. High Court Takes Up Netflix's Sales Tax Challenge

  By Sanjay Talwani

  The Colorado Supreme Court will determine whether Netflix's streaming video services are tangible personal property subject to sales tax, the justices said Monday, agreeing to review a state appeals court ruling in favor of the state Department of Revenue.

• Eli Lilly's $2.75B Pact Is Latest In AI Drug Discovery Push

  By Al Barbarino

  Eli Lilly and Co. has agreed to a partnership with artificial intelligence-driven drug discovery company Insilico that could be worth up to $2.75 billion, amid an expanding category of collaboration fueled by pharmaceutical giants seeking accelerated paths to new treatments. 

• Sotomayor Says Court Let Wrongful Murder Conviction Stand

  By Elizabeth Daley

  A man serving life in prison for a 1998 Louisiana murder was unfairly denied a writ of certiorari by the U.S. Supreme Court on Monday, despite the fact that his co-defendant had his conviction vacated when bringing up the same favorable evidence, dissenting justices said.

• Cognizant Hit With $8.4M Verdict Over NYU Prof's Firing

  By Pete Brush

  A Manhattan federal jury on Monday awarded $8.4 million to a New York University professor and former Cognizant Technology Solutions employee who claimed he was fired in retaliation for alleging the information technology company engaged in systematic hiring bias.

• Exchanges Are First Line In CFTC Prediction Market Policing

  By Aislinn Keely

  As the U.S. Commodity Futures Trading Commission insists it will be the primary cop for the growing expanse of prediction markets, experts said the agency is signaling that its first line of defense will be the internal enforcement programs of registrants like Kalshi.

• Justices Turn Away Case Over SEC Receivership Powers

  By Jessica Corso

  The U.S. Supreme Court on Monday rejected a plea by a Dallas real estate developer to hear a challenge to the U.S. Securities and Exchange Commission's ability to seize the assets of alleged fraudsters before a trial can take place.

• Justices Won't Review Juror Conduct In Ohio Rape Trial

  By Parker Quinlan

  The U.S. Supreme Court on Monday said it would not take up the case of an Ohio man seeking to have his rape conviction overturned because a juror admitted to potentially being biased but was still allowed to serve during his trial.

• High Court Turns Away CRISPR Patent Validity Dispute

  By Dani Kass

  The U.S. Supreme Court on Monday rejected Agilent Technologies' bid to revive patents on the gene-editing tool CRISPR, which centers on the burden of proof in establishing prior art.

• Justices Won't Examine Mich. Immunity In Pipeline Row

  By Keith Goldberg

  The U.S. Supreme Court on Monday refused to review a Sixth Circuit decision that greenlighted Enbridge Energy LP's lawsuit challenging Michigan's decision to revoke an easement for the company's controversial Line 5 oil and gas pipeline.